Cipla surges ~5% in early trade after settling litigation with Celgene Corporation

As part of the settlement, the Parties will file Consent Judgments in New Jersey that enjoin Cipla from marketing generic lenalidomide before the expiration of the patents-in-suit.

from India Infoline News Service https://ift.tt/3r1qZgz